|Global Edition

S&P 500 7,163 +0.77%NASDAQ 24,789 +1.44%BTC $77,793 -0.17%ETH $2,313 -0.92%SOL $85.13 -1.11%EUR/USD 1.1743 +0.50%GOLD 4,710 -0.66%S&P 500 7,163 +0.77%NASDAQ 24,789 +1.44%BTC $77,793 -0.17%ETH $2,313 -0.92%SOL $85.13 -1.11%EUR/USD 1.1743 +0.50%GOLD 4,710 -0.66%

GlobalMarkets

Today

Finance

Drug developer Seaport Therapeutics targets $912 million valuation in US IPO

Investing.com

April 27, 2026·1 min read

Finance

Drug developer Seaport Therapeutics targets $912 million valuation in US IPO

Original article

Drug developer Seaport Therapeutics targets $912 million valuation in US IPO

Published by Investing.com

Read full article